Related Experiment Video
Updated: May 7, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis
1Division of Molecular Diabetes Research, Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
Abstract:
Human cancers often exhibit attenuated microRNA (miRNA) biogenesis and global underexpression of miRNAs; thus, targeting the miRNA biogenesis pathway represents a novel strategy for cancer therapy. Here, we report that miR-26a enhances miRNA biogenesis, which acts as a common mechanism partially accounting for miR-26a function in diverse cancers including melanoma, prostate and liver cancer. miR-26a was broadly reduced in multiple cancers, and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo, including melanoma, prostate and liver cancers. Notably, miR-26a overexpression was accompanied by global upregulation of miRNAs, especially let-7, and let-7 expression was concordant with miR-26a expression in cancer cell lines, xenograft tumors and normal human tissues, underscoring their biological relevance. We showed that miR-26a directly targeted Lin28B and Zcchc11-two critical repressors of let-7 maturation. Furthermore, we have demonstrated that Zcchc11 promoted tumor growth and metastasis, and it was prominently overexpressed in human cancers. Our findings thus provide a novel mechanism by which a miRNA acts as a modulator of miRNA biogenesis. These results also define a role of the miR-26a and Zcchc11 in tumorigenesis and metastasis and have implications to develop new strategies for cancer therapy.
Insights
MicroRNA-26a (miR-26a) enhances microRNA biogenesis, suppressing tumor growth and metastasis in cancers like melanoma, prostate, and liver cancer. It targets repressors of let-7 maturation, offering a new cancer therapy strategy.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Human cancers often show reduced microRNA (miRNA) levels, suggesting miRNA biogenesis pathways are potential therapeutic targets.
- Restoring miRNA expression is a promising strategy for cancer treatment.
Purpose of the Study:
- To investigate the role of miR-26a in miRNA biogenesis and its impact on cancer progression.
- To identify the molecular mechanisms underlying miR-26a's tumor-suppressive functions.
Main Methods:
- Analysis of miRNA expression in various human cancers.
- Overexpression of miR-26a in cancer cell lines and in vivo models (melanoma, prostate, liver cancer).
- Luciferase assays to confirm direct targeting of Lin28B and Zcchc11 by miR-26a.
Main Results:
- miR-26a expression is reduced in multiple human cancers.
- Overexpression of miR-26a suppressed tumor growth and metastasis and led to global miRNA upregulation, particularly let-7.
- miR-26a directly targets and inhibits Lin28B and Zcchc11, key repressors of let-7 maturation.
- Zcchc11 was found to promote tumor growth and metastasis and was overexpressed in human cancers.
Conclusions:
- miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11, thereby suppressing tumor growth and metastasis.
- This study reveals a novel mechanism of miRNA-mediated regulation of miRNA biogenesis.
- The miR-26a/Lin28B/Zcchc11 axis represents a potential therapeutic target for various cancers.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
Experimental RNAi

